Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 2
2006 2
2007 2
2008 4
2009 3
2010 4
2011 2
2012 2
2013 8
2014 3
2015 6
2016 4
2017 12
2018 9
2019 9
2020 11
2021 11
2022 8
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis.
Caruso I, Di Gioia L, Di Molfetta S, Cignarelli A, Palmer SC, Natale P, Strippoli GFM, Perrini S, Natalicchio A, Laviola L, Giorgino F. Caruso I, et al. Among authors: laviola l. EClinicalMedicine. 2023 Sep 12;64:102181. doi: 10.1016/j.eclinm.2023.102181. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37719418 Free PMC article.
The p66Shc Redox Protein and the Emerging Complications of Diabetes.
Biondi G, Marrano N, Borrelli A, Rella M, D'Oria R, Genchi VA, Caccioppoli C, Cignarelli A, Perrini S, Laviola L, Giorgino F, Natalicchio A. Biondi G, et al. Among authors: laviola l. Int J Mol Sci. 2023 Dec 20;25(1):108. doi: 10.3390/ijms25010108. Int J Mol Sci. 2023. PMID: 38203279 Free PMC article. Review.
Glucagon in type 2 diabetes: Friend or foe?
Caruso I, Marrano N, Biondi G, Genchi VA, D'Oria R, Sorice GP, Perrini S, Cignarelli A, Natalicchio A, Laviola L, Giorgino F. Caruso I, et al. Among authors: laviola l. Diabetes Metab Res Rev. 2023 Mar;39(3):e3609. doi: 10.1002/dmrr.3609. Epub 2023 Jan 30. Diabetes Metab Res Rev. 2023. PMID: 36637256 Review.
Role of Glucose-Lowering Medications in Erectile Dysfunction.
Cignarelli A, Genchi VA, D'Oria R, Giordano F, Caruso I, Perrini S, Natalicchio A, Laviola L, Giorgino F. Cignarelli A, et al. Among authors: laviola l. J Clin Med. 2021 Jun 5;10(11):2501. doi: 10.3390/jcm10112501. J Clin Med. 2021. PMID: 34198786 Free PMC article. Review.
Insulin and Insulin Receptors in Adipose Tissue Development.
Cignarelli A, Genchi VA, Perrini S, Natalicchio A, Laviola L, Giorgino F. Cignarelli A, et al. Among authors: laviola l. Int J Mol Sci. 2019 Feb 11;20(3):759. doi: 10.3390/ijms20030759. Int J Mol Sci. 2019. PMID: 30754657 Free PMC article. Review.
The IGF-I signaling pathway.
Laviola L, Natalicchio A, Giorgino F. Laviola L, et al. Curr Pharm Des. 2007;13(7):663-9. doi: 10.2174/138161207780249146. Curr Pharm Des. 2007. PMID: 17346182 Review.
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
Penno G, Solini A, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Zerbini G, Lamacchia O, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group. Penno G, et al. BMC Med. 2021 Mar 15;19(1):66. doi: 10.1186/s12916-021-01936-3. BMC Med. 2021. PMID: 33715620 Free PMC article.
105 results